Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study

  • Jang, Jun Ho; 
  • Tomiyama, Yoshiaki; 
  • Miyazaki, Koji; 
  • Nagafuji, Koji; 
  • Usuki, Kensuke; 
  • 외 17명
Citations

WEB OF SCIENCE

51
Citations

SCOPUS

56

초록

A previous dose-finding study has suggested that romiplostim is effective in patients with refractory aplastic anaemia (AA) and 10 mu g/kg once weekly was recommended as a starting dose. In this Phase II/III, multicentre, open-label study, romiplostim was administered subcutaneously at a fixed dose of 10 mu g/kg once weekly for 4 weeks (weeks 1-4) followed by weekly doses (5, 10, 15 and 20 mu g/kg) titrated by platelet response for up to 52 weeks (weeks 5-52). A total of 31 patients with AA who were refractory to immunosuppressive therapy (IST) and thrombocytopenia (platelet count of <= 30 x 10(9)/l) were enrolled. The primary efficacy endpoint of the proportion of patients achieving any haematological (platelet, neutrophil and erythrocyte) response at week 27 was 84% [95% confidence interval (CI) 66-95%]. Trilineage response was 39% (95% CI 22-58%) at week 53. The most common treatment-related adverse events (AEs) were headache and muscle spasms (each 13%). All AEs were mild or moderate except for three patients with Grade 3 hepatic AEs; no AEs necessitated romiplostim discontinuation. Two patients developed cytogenetic abnormalities, of whom one returned to normal karyotype at last follow-up. High-dose romiplostim is effective and well tolerated in the treatment of patients with AA refractory to IST.

키워드

aplastic anaemia; bone marrow failure; haematopoiesis; thrombopoietin; RECEPTOR; HEMATOPOIESIS; ELTROMBOPAG; MANAGEMENT; DIAGNOSIS
제목
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study
저자
Jang, Jun Ho; Tomiyama, Yoshiaki; Miyazaki, Koji; Nagafuji, Koji; Usuki, Kensuke; Uoshima, Nobuhiko; Fujisaki, Tomoaki; Kosugi, Hiroshi; Matsumura, Itaru; Sasaki, Ko; Kizaki, Masahiro; Sawa, Masashi; Hidaka, Michihiro; Kobayashi, Naoki; Ichikawa, Satoshi; Yonemura, Yuji; Enokitani, Kouki; Matsuda, Akira; Ozawa, Keiya; Mitani, Kinuko; Lee, Jong Wook; Nakao, Shinji
DOI
10.1111/bjh.17190
발행일
2021-01
유형
Article
저널명
British Journal of Haematology
권
192
호
1
페이지
190 ~ 199